Immunology

Latest News

The model’s predictions were in line with established cell distributions within each phenotype of rheumatoid arthritis. | Image credit: ArtemisDiana - stock.adobe.com
Machine Learning Effectively Characterizes Rheumatoid Arthritis Subtypes

September 6th 2024

Investigators noted that a formal independent validation cohort needs to be developed to realize the full potential of the human model.

Bimekizumab showed sustained, consistent effectiveness to 52 weeks with or without methotrexate in psoriatic arthritis. | Image credit: stockdevil - stock.adobe.com
Bimekizumab Shows Persistent Efficacy, Safety in Psoriatic Arthritis at 52 Weeks

August 22nd 2024

Findings suggest checking regular radiographs in clinical practice for loss of bone density or VFs can be helpful in managing axial spondyloarthritis. - Mutshino_Artwork - stock.adobe.com
Long-Term TNFi Treatment for AxSpA Improved, Maintained Bone Mineral Density

August 16th 2024

AJMC
Geographic Variability of Medicaid Acceptance Among Allergists in the US

August 15th 2024

Disease control was linked with better quality of life among patients with psoriatic arthritis. | Image credit: Evrymmnt - stock.adobe.com
Clinical Disease Control in Psoriatic Artiritis Improves Quality of Life

August 9th 2024

Exploring a Chronic and Painful Inflammatory Skin Disease

Join us as Dr. Iltefat Hamzavi shares insights into hidradenitis suppurativa. Learn about its signs, symptoms, differential diagnosis, and treatment strategies, as Dr. Hamzavi highlights the impact on patients and families.

Join us as Dr. Iltefat Hamzavi shares insights into hidradenitis suppurativa. Learn about its signs, symptoms, differential diagnosis, and treatment strategies, as Dr. Hamzavi highlights the impact on patients and families.

More News

Health insurance blocks | Image Credit: REDPIXEL - stock.adobe.com
March 13th 2024

New Study Links Social Factors to Hidradenitis Suppurativa Severity

Giuliana Grossi
Research presented at the American Academy of Dermatology Annual Meeting 2024 explored the impact of social determinants of health on hidradenitis suppurativa severity.
Healthy foods | Image credit: Rodica Ciorba - stock.adobe.com
March 8th 2024

Dietary Interventions Reduce CVD Risk in RA and SpA

Laura Joszt, MA
While dietary interventions do not significantly change the body composition of patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA), they can reduce the risk of cardiovascular disease (CVD).
Health care concept meaning Hidradenitis suppurativa with inscription on the page | Image Credit: Yurii Kibalnik - stock.adobe.com
March 6th 2024

Authors Review Emerging Therapeutic Targets for Hidradenitis Suppurativa

Giuliana Grossi
Despite its impact on patient quality of life, hidradenitis suppurativa (HS) remains underdiagnosed and undertreated; authors outline what's being discovered within the treatment landscape.
Inflammatory bowel disease - Vitalii Vodolazskyi - stock.adobe.com.jpg
February 26th 2024

Psoriasis Severity Tied to Increased Risk of Inflammatory Bowel Disease

Giuliana Grossi
A recent study identified a significant association between psoriasis and inflammatory bowel disease. This link also applied to IBD subtypes: Crohn disease and ulcerative colitis.
Epstein-Barr virus | Image: Dr Microbe
February 23rd 2024

As FDA Filing Approaches for Tab-Cel in EBV+ PTLD, Decades of Science Bear Fruit

Mary Caffrey
Approved in Europe, tabelecleucel may soon be considered by FDA to treat patients who develop Epstein-Barr virus following a transplant, which then triggers a type of deadly lymphoma that may not respond to traditional therapy. Tab-cel, an allogeneic T-cell therapy, comes 30 years after the discovery that T cells might offer hope, followed by decades of research on how to harness them without the side effects.
Woman with psoriasis | Andrey Popov - stock.adobe.com
February 20th 2024

From Psoriasis to PsA: Study Identifies Predictive Factors for Development

Giuliana Grossi
Findings reveal an increased risk of psoriatic arthritis (PsA) among female patients with severe skin psoriasis who have nail involvement and require oral systemic therapy for their condition.
COVID-19 Vaccine Bottle With Syringe | image credit: myskin - stock.adobe.com
December 31st 2023

Patients With RA Receiving DMARDs Have Reduced COVID-19 Vaccine Immune Responses, Study Finds

Kyle Munz
A cross-sectional study finds that patients with rheumatoid arthritis receiving disease-modifying antirheumatic drugs (DMARDs) exhibit a reduced immune response to the COVID-19 vaccine compared with controls.
Man With Lupus Erythematosus | image credit: velimir - stock.adobe.com
December 27th 2023

Afimetoran Shown to Be Safe, Well-Tolerated for Patients With Cutaneous Lupus Erythematosus

Tim Smith
This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with cutaneous lupus erythematosus (CLE).
Woman Enduring Rheumatoid Arthritis | image credit: doucefleur - stock.adobe.com
December 23rd 2023

Training Initiative for Management of Rheumatoid Arthritis Shows Promise in Native American Communities

Tim Smith
This new program was designed to be a scalable model for the formulation of similar initiatives in communities known to have limited access to specialized care for rheumatic conditions.
Rheumatoid Arthritis Flare | image credit: doucefleur - stock.adobe.com
December 8th 2023

Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases

Tim Smith
New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Autoimmune Thyroid Disease Model | image credit: Jo Panuwat D - stock.adobe.com
November 28th 2023

Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease

Kyle Munz
A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Lupus Written With Marker | MP Studio - stock.adobe.com
October 4th 2023

IFGBP-2 Levels Indicative of Renal Prognosis in Pediatric Lupus Nephritis, Study Finds

Kyle Munz
In a cross-sectional study, insulin growth factor binding protein 2 (IFGBP-2) showed promise as a prognosis biomarker for renal disease in pediatric lupus nephritis (LN).
Group supporting one another
September 8th 2023

Social Support Linked to Better Quality of Life in Patients With Lupus

Lana Pine
Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.
vitamin D capsule held up to the sky
September 5th 2023

Vitamin D Deficiency Linked With High Inflammation and BMD Decline in Patients With SLE

Justina Petrullo
Vitamin D deficiency is associated with high inflammation and bone mineral density (BMD) decline in patients with systemic lupus erythematosus (SLE).
emergency department sign
August 7th 2023

Frailty Increases Repeated ED Visits in Adults at or Under Age 65 With SLE, Study Suggests

Justina Petrullo
Adults at or under the age of 65 years who are frail and have systemic lupus erythematosus (SLE) increased the likelihood of repeated emergency department visits.
a woman is lying down in the fetal position
July 13th 2023

Certain Gut Bacteria May Promote Disease Activity in Patients With Lupus Nephritis

Justina Petrullo
A study suggests that strains of ruminococcus (blautia) gnavus (RG) seen in the gut microbiome of patients in active lupus nephritis might be drivers of disease flares and highlight the possible pathogenic qualities of specific strains.
<12

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo